| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.00B | +28.5% |
| R&D Expense | $295.9M | -9.7% |
| SG&A Expense | $550.3M | +9.8% |
| Operating Income | $55.4M | +133.6% |
| Pre-tax Income | $24.1M | +112.3% |
| Income Tax | $1.7M | +48.2% |
| Net Income | $22.4M | +111.3% |
| EPS (Basic) | $0.18 | +111.3% |
| EPS (Diluted) | $0.20 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $466.2M | +13.4% |
| Accounts Receivable | $366.2M | +38.2% |
| Inventory | $142.6M | +75.1% |
| Current Assets | $1.01B | +28.6% |
| Total Assets | $1.08B | +21.5% |
| Current Liabilities | $323.6M | +74.4% |
| Total Liabilities | $705.1M | +7.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.3M | +151.6% |
| Capital Expenditures | $313K | -22.3% |
| Investing Cash Flow | -$313K | +22.3% |
| Financing Cash Flow | $8.9M | -94.0% |
| Free Cash Flow | $45.0M | +151.0% |
| +112.5% |
| Stockholders' Equity |
| $370.1M |
| +62.0% |